Bibliography
Koppal, T., Subramaniam, R., Drake, J., Prasad, M. R., Dhillon, H., & Butterfield, D. A. (1998). Vitamin E protects against Alzheimerâs amyloid peptide (25â35)-induced changes in neocortical synaptosomal membrane lipid structure and composition. Brain Research, 786(1â2), 270â273.
References
21
Referenced
60
10.1139/o59-099
/ Can. J. Biochem. Physiol. / A rapid method of total lipid extraction and purification by Bligh (1959)10.1021/tx960130e
/ Chem. Res. Toxicol. / β-amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease by Butterfield (1997)10.1006/bbrc.1994.1508
/ Biochem. Biophys. Res. Commun. / β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease by Butterfield (1994)10.1089/neu.1994.11.405
/ J. Neurotrauma / Regional levels of free fatty acids and Evans Blue extravasation after experimental brain injury by Dhillon (1994)10.1016/0006-8993(94)91586-5
/ Brain Res. / Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation by Goodman (1994){'key': '10.1016/S0006-8993(97)01466-2_BIB6', 'first-page': '1', 'article-title': "Direct evidence of oxidative injury produced by the Alzheimer's amyloid beta protein (1–40) in cultured hippocampal neurons", 'volume': '132', 'author': 'Harris', 'year': '1995', 'journal-title': 'Exp. Neurol.'}
/ Exp. Neurol. / Direct evidence of oxidative injury produced by the Alzheimer's amyloid beta protein (1–40) in cultured hippocampal neurons by Harris (1995)10.1073/pnas.91.8.3270
/ Proc. Natl. Acad. Sci. U.S.A. / A model for β-amyloid aggregation and neurotoxicity based on free radical generated by the peptide: relevance to Alzheimer's disease by Hensley (1994)10.1016/0891-5849(94)90018-3
/ Free Radic. Biol. Med. / Electron paramagnetic resonance investigation of free radical induced alterations in neocortical synaptosomal membrane protein infrastructure by Hensley (1994)10.1096/fasebj.5.3.2001787
/ FASEB J. / Advances in Alzheimer's disease by Katzman (1991)10.1016/S0021-9258(19)52451-6
/ J. Biol. Chem. / Protein measurement with the Folin phenol reagent by Lowry (1951)10.1523/JNEUROSCI.15-09-06239.1995
/ J. Neurosci. / Amyloid β-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death by Mark (1995)10.1046/j.1471-4159.1997.68010255.x
/ J. Neurochem. / Evidence that 4-hydroxynonenal mediates disruption of ion homeostasis and neuronal death by amyloid-β peptide by Mark (1997)10.1006/bbrc.1996.0699
/ Biochem. Biophys. Res. Commun. / Alzheimer's disease amyloid β peptide 25–35 is localized in the membrane hydrocarbon core: X-ray diffraction analysis by Mason (1996)10.1016/0166-2236(93)90009-B
/ Trends Neurosci. / β-Amyloid precursor protein metabolites and loss of neuronal Ca+2 homeostasis Alzheimer's disease by Mattson (1993)10.1016/S0021-9258(19)49575-6
/ J. Biol. Chem. / Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition by Pentland (1992)10.1016/0005-2736(85)90203-2
/ Biochim. Biophys. Acta / Estimation of the location of natural α-tocopherol in lipid bilayers by 13C-NMR spectroscopy by Perly (1985)10.1016/0891-5849(90)90153-A
/ Free Radic. Biol. Med. / Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autooxidation of polyunsaturated fatty acids by Pyror (1990)10.1056/NEJM199704243361704
/ New Engl. J. Med. / A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study by Sano (1997)10.1074/jbc.271.31.18295
/ J. Biol. Chem. / Amyloid β-protein and the genetics of Alzheimer's disease by Selkoe (1996)10.1046/j.1471-4159.1997.69031161.x
/ J. Neurochem. / The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters conformation of cortical synaptosomal membrane proteins by Subramaniam (1997)10.1111/j.1749-6632.1989.tb22604.x
/ Anal. N.Y. Acad. Sci. / Cerebrospinal fluid eicosanoids as an index of cerebrovascular status by White (1989)
Dates
Type | When |
---|---|
Created | 22 years, 7 months ago (Jan. 9, 2003, 7:13 a.m.) |
Deposited | 4 years, 3 months ago (May 5, 2021, 6:16 a.m.) |
Indexed | 1 week, 2 days ago (Aug. 21, 2025, 1:34 p.m.) |
Issued | 27 years, 5 months ago (March 1, 1998) |
Published | 27 years, 5 months ago (March 1, 1998) |
Published Print | 27 years, 5 months ago (March 1, 1998) |
@article{Koppal_1998, title={Vitamin E protects against Alzheimer’s amyloid peptide (25–35)-induced changes in neocortical synaptosomal membrane lipid structure and composition}, volume={786}, ISSN={0006-8993}, url={http://dx.doi.org/10.1016/s0006-8993(97)01466-2}, DOI={10.1016/s0006-8993(97)01466-2}, number={1–2}, journal={Brain Research}, publisher={Elsevier BV}, author={Koppal, Tanuja and Subramaniam, Ram and Drake, Jennifer and Prasad, M.Renuka and Dhillon, Harbhajan and Butterfield, D.Allan}, year={1998}, month=mar, pages={270–273} }